SunAct Cancer Institute has announced the commencement of Phase 2 clinical trials for Gamma Delta (gd) T-cell therapy, a ...
Industry leaders outline priorities for healthcare, including AI integration, infrastructure expansion, and policy reforms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback